PB
NVO

Pinnacle Bancorp’s Novo Nordisk NVO Stock Holding History

Pinnacle Bancorp’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.8K Buy
852
+160
+23% +$6.87K 0.01% 493
2026
Q1 		$25.4K Buy
692
+150
+28% +$7.11K 0.01% 561
2025
Q4 		$27.6K Hold
542
– – 0.01% 535
2025
Q3 		$30.1K Hold
542
– – 0.01% 536
2025
Q2 		$37.4K Sell
542
-400
-42% -$27.2K 0.01% 481
2025
Q1 		$65.4K Sell
942
-554
-37% -$45.8K 0.02% 373
2024
Q4 		$129K Buy
1,496
+336
+29% +$36.3K 0.04% 274
2024
Q3 		$138K Buy
1,160
+118
+11% +$15.7K 0.04% 253
2024
Q2 		$149K Hold
1,042
– – 0.04% 234
2024
Q1 		$134K Hold
1,042
– – 0.04% 248
2023
Q4 		$108K Buy
1,042
+500
+92% +$49.4K 0.04% 265
2023
Q3 		$49.3K Hold
542
– – 0.02% 365
2023
Q2 		$43.9K Hold
542
– – 0.02% 397
2023
Q1 		$43.1K Hold
542
– – 0.02% 382
2022
Q4 		$37K Hold
542
– – 0.01% 380
2022
Q3 		$27K Sell
542
-144
-21% -$7.71K 0.01% 411
2022
Q2 		$38K Hold
686
– – 0.02% 364
2022
Q1 		$38K Sell
686
-32
-4% -$1.64K 0.01% 378
2021
Q4 		$40K Hold
718
– – 0.01% 382
2021
Q3 		$34K Buy
718
+110
+18% +$5.32K 0.01% 400
2021
Q2 		$25K Hold
608
– – 0.01% 461
2021
Q1 		$20K Sell
608
-704
-54% -$25.1K 0.01% 496
2020
Q4 		$46K Hold
1,312
– – 0.03% 335
2020
Q3 		$46K Buy
1,312
+238
+22% +$7.93K 0.03% 320
2020
Q2 		$35K Hold
1,074
– – 0.03% 335
2020
Q1 		$32K Sell
1,074
-800
-43% -$23.8K 0.03% 324
2019
Q4 		$54K Sell
1,874
-406
-18% -$11.2K 0.04% 292
2019
Q3 		$59K Buy
2,280
+406
+22% +$10.3K 0.03% 274
2019
Q2 		$48K Buy
1,874
+246
+15% +$6.08K 0.03% 310
2019
Q1 		$43K Sell
1,628
-100
-6% -$2.46K 0.02% 322
2018
Q4 		$40K Buy
+1,728
New +$38.4K 0.02% 316
2017
Q1 		$23K Buy
+1,348
New +$23.5K 0.02% 397

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Pinnacle Bancorp's NVO Position: Q2 2026 in Review

Pinnacle Bancorp increased its Novo Nordisk (NVO) stake by 23% in Q2 2026, buying an estimated $6.87K and bringing the position to 852 shares worth $40.8K. The position accounts for 0.01% of the portfolio, ranked #493.

Pinnacle Bancorp first reported a position in NVO in Q1 2017 and has held it in 32 quarters since. The position peaked at $149K in Q2 2024. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Pinnacle Bancorp held 852 shares of Novo Nordisk worth $40.8K as of Q2 2026.
  • Pinnacle Bancorp bought 160 Novo Nordisk shares in Q2 2026, an estimated $6.87K.
  • Novo Nordisk made up 0.01% of Pinnacle Bancorp's portfolio in Q2 2026, its #493 holding.
  • Pinnacle Bancorp first reported a position in Novo Nordisk in Q1 2017 and has held it in 32 quarters since.
  • Pinnacle Bancorp's Novo Nordisk position peaked at $149K in Q2 2024.
  • 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Pinnacle Bancorp's 13F filing for Q2 2026, filed 28 Jul 2026.